Search research articles
Contact Us
Filters
Showing results (21-30 of 342) with videos related to
Page
of 35
Sort By:
Advances in Parasitology
|
February 7, 2013
The epidemiology of Plasmodium vivax. Preface
Simon I Hay, Ric N Price, J Kevin Baird
Current Opinion in Infectious Diseases
|
July 3, 2009
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Ric N Price, Nicholas M Douglas, Nicholas M Anstey
International Journal of Epidemiology
|
December 17, 2021
Malaria eradication revisited
Nicholas M Douglas, Thomas R Burkot, Ric N Price
Malaria Journal
|
April 24, 2009
The effect of varying analytical methods on estimates of anti-malarial clinical efficacy
Wendy J Verret, Grant Dorsey, Francois Nosten, et al.
Trends in Parasitology
|
April 8, 2009
The pathophysiology of vivax malaria
Nicholas M Anstey, Bruce Russell, Tsin W Yeo, et al.
The Lancet. Infectious Diseases
|
January 16, 2025
Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics
Constanze Ciavarella, Chris Drakeley, Ric N Price, et al.
BMC Medical Ethics
|
March 8, 2018
The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial
Phaik Yeong Cheah, Norbert Steinkamp, Lorenz von Seidlein, et al.
The American Journal of Tropical Medicine and Hygiene
|
May 16, 2018
Malaria Elimination: Time to Target All Species
Andrew A Lover, J Kevin Baird, Roly Gosling, et al.
Malaria Journal
|
September 23, 2015
A systematic review of sub-microscopic Plasmodium vivax infection
Clarissa M Moreira, Mahmoud Abo-Shehada, Ric N Price, et al.
Current Opinion in Infectious Diseases
|
October 12, 2011
Plasmodium vivax treatments: what are we looking for?
Ric N Price, Nicholas M Douglas, Nicholas M Anstey, et al.
Page
of 35
Search research articles
Search
Showing results (21-30 of 342) with videos related to
Sort By:
Page
of 35
Advances in Parasitology
|
February 7, 2013
The epidemiology of Plasmodium vivax. Preface
Simon I Hay, Ric N Price, J Kevin Baird
Current Opinion in Infectious Diseases
|
July 3, 2009
New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance
Ric N Price, Nicholas M Douglas, Nicholas M Anstey
International Journal of Epidemiology
|
December 17, 2021
Malaria eradication revisited
Nicholas M Douglas, Thomas R Burkot, Ric N Price
Malaria Journal
|
April 24, 2009
The effect of varying analytical methods on estimates of anti-malarial clinical efficacy
Wendy J Verret, Grant Dorsey, Francois Nosten, et al.
Trends in Parasitology
|
April 8, 2009
The pathophysiology of vivax malaria
Nicholas M Anstey, Bruce Russell, Tsin W Yeo, et al.
The Lancet. Infectious Diseases
|
January 16, 2025
Quantifying Plasmodium vivax radical cure efficacy: a modelling study integrating clinical trial data and transmission dynamics
Constanze Ciavarella, Chris Drakeley, Ric N Price, et al.
BMC Medical Ethics
|
March 8, 2018
The ethics of using placebo in randomised controlled trials: a case study of a Plasmodium vivax antirelapse trial
Phaik Yeong Cheah, Norbert Steinkamp, Lorenz von Seidlein, et al.
The American Journal of Tropical Medicine and Hygiene
|
May 16, 2018
Malaria Elimination: Time to Target All Species
Andrew A Lover, J Kevin Baird, Roly Gosling, et al.
Malaria Journal
|
September 23, 2015
A systematic review of sub-microscopic Plasmodium vivax infection
Clarissa M Moreira, Mahmoud Abo-Shehada, Ric N Price, et al.
Current Opinion in Infectious Diseases
|
October 12, 2011
Plasmodium vivax treatments: what are we looking for?
Ric N Price, Nicholas M Douglas, Nicholas M Anstey, et al.
Page
of 35